Literature DB >> 1814434

Protein kinase C activation and protooncogene expression in differentiation/retrodifferentiation of human U-937 leukemia cells.

R Hass1, H J Pfannkuche, S Kharbanda, H Gunji, G Meyer, A Hartmann, H Hidaka, K Resch, D Kufe, M Goppelt-Strübe.   

Abstract

Human U-937 leukemia cells differentiate along the monocytic lineage following 3-day exposures to 12-O-tetradecanoylphorbol-13-acetate (TPA). This induction of differentiation is accompanied by adherence and loss of proliferation, as well as expression/repression of differentiation-associated genes. Long term culture of TPA-differentiated U-937 cells in the absence of phorbol ester for 32-36 days resulted in a process of retrodifferentiation. The retrodifferentiated cells detached from the substrate and reinitiated proliferation. Other cellular parameters, such as glycosidase activities, cytokine release, and filament expression, returned to levels similar to that observed in uninduced cells. Treatment of U-937 cells with TPA resulted in a rapid translocation of protein kinase C (PKC) from the cytosol to cell membrane fractions within 2-8 min. Increased levels of membrane-associated PKC activity persisted until 17-29 days. However, longer periods of incubation were associated with a return to the distribution of PKC in control cells. Activation of PKC has been implicated in the regulation of certain immediate early response genes, and in the present studies, TPA rapidly induced c-fos and c-jun gene expression. Levels of c-fos and c-jun transcripts remained elevated during periods of PKC activation and also returned to levels observed in control cells by 30-36 days, when the cells entered retrodifferentiation. Staurosporine, a nonspecific inhibitor of PKC, partially blocked TPA-induced adherence and growth inhibition and concomitantly prevented TPA-induced c-fos and c-jun gene expression.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1814434

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  10 in total

Review 1.  Regulation of monocyte differentiation by specific signaling modules and associated transcription factor networks.

Authors:  René Huber; Daniel Pietsch; Johannes Günther; Bastian Welz; Nico Vogt; Korbinian Brand
Journal:  Cell Mol Life Sci       Date:  2013-03-24       Impact factor: 9.261

Review 2.  Protein kinase C isoenzymes: divergence in signal transduction?

Authors:  H Hug; T F Sarre
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

3.  Internucleosomal DNA fragmentation during phorbol ester-induced monocytic differentiation and G0/G1 arrest.

Authors:  H Gunji; R Hass; D Kufe
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

4.  Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8).

Authors:  Monica L Guzman; Xiaojie Li; Cheryl A Corbett; Randall M Rossi; Timothy Bushnell; Jane L Liesveld; Josée Hébert; Fay Young; Craig T Jordan
Journal:  Blood       Date:  2007-09-04       Impact factor: 22.113

5.  Gossypol acetic acid induces apoptosis in RAW264.7 cells via a caspase-dependent mitochondrial signaling pathway.

Authors:  Sijun Deng; Hui Yuan; Jine Yi; Yin Lu; Qiang Wei; Chengzhi Guo; Jing Wu; Liyun Yuan; Zuping He
Journal:  J Vet Sci       Date:  2013-06-30       Impact factor: 1.672

6.  The cannabinoid receptors agonist WIN55212-2 inhibits macrophageal differentiation and alters expression and phosphorylation of cell cycle control proteins.

Authors:  Katrin Paulsen; Svantje Tauber; Johanna Timm; Nadine Goelz; Claudia Dumrese; Alexandra Stolzing; Ralf Hass; Oliver Ullrich
Journal:  Cell Commun Signal       Date:  2011-12-28       Impact factor: 5.712

Review 7.  Towards selective pharmacological modulation of protein kinase C--opportunities for the development of novel antineoplastic agents.

Authors:  A Gescher
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

Review 8.  Cancer stem cell niche models and contribution by mesenchymal stroma/stem cells.

Authors:  Catharina Melzer; Juliane von der Ohe; Hendrik Lehnert; Hendrik Ungefroren; Ralf Hass
Journal:  Mol Cancer       Date:  2017-02-01       Impact factor: 27.401

9.  The differentiation/retrodifferentiation program of human U937 leukemia cells is accompanied by changes of VCP/p97.

Authors:  Catharina Bertram; Nils von Neuhoff; Britta Skawran; Doris Steinemann; Brigitte Schlegelberger; Ralf Hass
Journal:  BMC Cell Biol       Date:  2008-02-15       Impact factor: 4.241

Review 10.  Altered Tumor Plasticity after Different Cancer Cell Fusions with MSC.

Authors:  Catharina Melzer; Juliane von der Ohe; Ralf Hass
Journal:  Int J Mol Sci       Date:  2020-11-06       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.